• About
  • Subscribe
  • Advertise
  • Contact
Thursday, January 15, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

When should patients be operated on post-SARS-CoV-2 infection?

by Myles Hume
August 12, 2020
in Local, News
Reading Time: 3 mins read
A A
Researchers are working out how the respiratory, cardiovascular and other systems may be affected from infection.

Researchers are working out how the respiratory, cardiovascular and other systems may be affected from infection.

Share on FacebookShare on Twitter

RANZCO has warned that patients diagnosed with SARS-CoV-2 in close proximity to their elective surgery may be at risk of post-operative complications, as it released new guidelines on the appropriate timing for surgery on patients who have recovered from active infection.

Despite there not yet being a full understanding of the long term effects of SARS-CoV-2 infection, the college is recommending that previously diagnosed patients are symptom-free for a minimum of two months before undergoing surgery, and that the cardiac and respiratory systems are subjected to a clinical review.

The updated advice, which does not preclude cataract surgery, was published on 5 August by RANZCO president Associate Professor Heather Mack and Victorian branch chair Dr David van der Straaten. It was formed in conjunction with their counterparts from The Royal Australasian College of Surgeons, The Australian and New Zealand College of Anaesthetists and The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Heather Mack.

Entitled ‘Guidance on delay to elective surgery post recovery from SARS-COV-2 infection’, the document is said to provide “good guidance for all our members in a rapidly developing field”. It is particularly relevant to specialists in Victoria where there are some 14,700 active cases.

The colleges point out that the severity and duration of SARS-CoV-2 infection is variable between individuals. However, there is increasing evidence of post infection impairment despite significant gaps in understanding how long the respiratory, cardiovascular and other systems may be affected.

They also state that infection (communicability) recovery appears to be much quicker than physiologic recovery.

“Available evidence suggests patients who had SARS-CoV-2 infection diagnosed within seven days before or up to 30 days after surgery are at significant risk of post-operative complications including increased morbidity and mortality,” the guideline states.

“There are insufficient additional data to provide universal recommendations on the optimum timing of necessary, planned surgery following recovery from active infection with SARS-CoV-2. Therefore, a cautious approach is recommended. Decisions regarding surgical timing will require careful consideration of the possible sequelae of the infection, the urgency of the required surgery and the expected physiological impact on the patient.”

As such, RANZCO and other medical colleges recommended patients are symptom free for a minimum of eight weeks prior to undergoing all but minor elective surgical procedures.

They recommended that patients have a formal clinical review prior to surgery that addresses the state of the cardiac and respiratory systems. This is recommended for all patients post-known SARS-CoV-2 infection and is especially important for those who have persisting symptoms (including fatigue) or who were hospitalised for care.

The college added: “If, on careful consideration of the nature and severity of any persisting problems, delay is considered the safer course of action for an individual patient, we recommend treatment is delayed until the balance of risks and benefits are more in the patient’s favour, even for a Category 1 (within 30 days) case.”

The document was generated out of a meeting chaired by Professor David Watters of Safer Care Victoria. Each Friday, he heads a meeting of all the surgical groups in the peri-operative space in Victoria where they learn about the state supply of personal protective equipment and experiences of the various hospital networks, among other things.

The guidance will be updated when more evidence of the longer term’s effects of infection with SARS-CoV-2 is available, RANZCO stated.

The guidelines can be found here.

More reading

Private sector apprehensive to perform public surgery ‘blitz’ at discount rates

AMD patients at higher risk of COVID-19 death

Surgeries on hold in regions to boost hospital capacity

COVID-19 detected after eye exams of asymptomatic patients

 

Tags: cardiovascularelective surgeryperioperativeRANZCOrespiratorySARS-CoV-2 infectionThe Australian and New Zealand College of AnaesthetistsThe Royal Australasian College of SurgeonsThe Royal Australian and New Zealand College of Obstetricians and Gynaecologists

Related Posts

Previous winner of the ODA National Medal for Optical Dispensing Excellence, Dominique Jorgensen (right), with ODA chief executive April Petrusma, and Todd Spencer of CR Labs. Image: Insight

Nominations open for 2026 ODA National Excellence Awards

by Staff Writer
January 15, 2026

Optical Dispensers Australia (ODA) has opened nominations for the 2026 ODA National Excellence Awards, offering what it calls a unique...

Image: sulit.photos/stock.adobe.com

People on the move – January 2026

by Staff Writer
January 14, 2026

Welcome to People on the move – January 2026, Insight’s monthly bulletin to keep the Australian ophthalmic sector updated on new appointments and...

Moorfields consultant ophthalmologist and lead author of the study, Dr Harry Petrushkin, and patient Nicki Guy. Image: Moorfields Eye Hospital

World-first study shows promising treatment for hypotony with common eye injection

by Staff Writer
January 14, 2026

A pioneering clinical project by researchers at University College London (UCL) and Moorfields Eye Hospital has demonstrated that a widely...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited